Our social responsibility strategy introduces new long-term ambitions in three areas critical to help improve individual and public health:
- Preventing the rise of type 2 diabetes and obesity.
- Providing access to affordable care for vulnerable patients in every country.
- Driving innovation to improve lives.
Today, one in every 11 people in the world has diabetes, a figure that is projected to rise to one in nine by 2045 if action is not taken.
Diabetes places a great burden on health systems, and we are committed to work with health authorities and other partners in the countries where we operate, to prevent and treat the disease.
No child should die from type 1 diabetes
We are expanding our Changing Diabetes® in Children programme to reach 100,000 children by 2030. Already, our programme has helped more than 30,000 children with type 1 diabetes get access to medical care and life-saving medicine in low-resource settings.
Affordable human insulin in low- and middle-income countries
We have reduced the ceiling price of human insulin from USD 4 to USD 3 per vial in 76 low- and middle-income countries. This is a vital expansion of our Access to Insulin Commitment to strengthen our efforts to reach the most vulnerable people with low-cost insulin.
Improved care for vulnerable populations
We are extending our Partnering for Change programme with the International Committee of the Red Cross and the Danish Red Cross until 2023. Additionally we are supporting with a donation of DKK 15 million to the programme. Through our joint efforts, the programme helps the most vulnerable patient groups during humanitarian crises.
